Oxidative Reactive Species in Cell Injury: Mechanisms in Diabetes Mellitus and Therapeutic Approaches

Abstract: Mammalian cells are continuously subject to insult from reactive species. Most of the pathogenic mechanisms that have been considered to date reflect overproduction of reactive oxygen species (ROS) or a peculiar failure in intracellular defenses against ROS. We have attempted to consider briefly the most important mechanisms of ROS production, defense, and reactive species‐induced cell damage and approaches to therapy, focusing on the example of diabetes mellitus. An improved understanding of these mechanisms should facilitate development of antioxidant intervention strategies leading to reduction in diseases associated with oxidative stress.

[1]  W. Dröge Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[2]  K. Polonsky,et al.  Visualizing Superoxide Production in Normal and Diabetic Rat Islets of Langerhans* , 2003, The Journal of Biological Chemistry.

[3]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Ju,et al.  UCP-mediated energy depletion in skeletal muscle increases glucose transport despite lipid accumulation and mitochondrial dysfunction. , 2004, American journal of physiology. Endocrinology and metabolism.

[5]  K. Park,et al.  Decreased mitochondrial DNA content in peripheral blood precedes the development of non-insulin-dependent diabetes mellitus. , 1998, Diabetes research and clinical practice.

[6]  P. Brookes,et al.  Calcium, ATP, and ROS: a mitochondrial love-hate triangle. , 2004, American journal of physiology. Cell physiology.

[7]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[8]  K. Petersen,et al.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.

[9]  Joseph L Evans,et al.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? , 2003, Diabetes.

[10]  M. Owen,et al.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.

[11]  R. Wiesner,et al.  Regulation and Co‐Ordination of Nuclear Gene Expression During Mitochondrial Biogenesis , 2003, Experimental physiology.

[12]  C. Chan,et al.  Uncoupling protein-2: evidence for its function as a metabolic regulator , 2002, Diabetologia.

[13]  G. King,et al.  The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO‐MCBN, the American Diabetes Association and the German Diabetes Society , 2001, Diabetes/metabolism research and reviews.

[14]  J. Lawrence,et al.  Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. , 2001, Diabetes.

[15]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[16]  J. Leszyk,et al.  Mitochondrial Biogenesis and Remodeling during Adipogenesis and in Response to the Insulin Sensitizer Rosiglitazone , 2003, Molecular and Cellular Biology.

[17]  A. Rudich,et al.  Oxidative Stress Disrupts Insulin-induced Cellular Redistribution of Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes , 1999, The Journal of Biological Chemistry.

[18]  Catherine B. Chan,et al.  Mitochondrial Functional State in Clonal Pancreatic β-Cells Exposed to Free Fatty Acids* , 2003, Journal of Biological Chemistry.

[19]  Hajime Otani,et al.  Reactive oxygen species as mediators of signal transduction in ischemic preconditioning. , 2004, Antioxidants & redox signaling.

[20]  M. Vasson,et al.  An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. , 2003, Metabolism: clinical and experimental.

[21]  S. Lenzen,et al.  Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells , 1997, Diabetes.

[22]  M. Brand,et al.  Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. , 2004, Diabetes.

[23]  V. Hughes,et al.  Increased Prevalence of Mitochondrial DNA Deletions in Skeletal Muscle of Older Individuals With Impaired Glucose Tolerance: Possible Marker of Glycemic Stress , 1997, Diabetes.

[24]  H. Lebovitz,et al.  Treatment of insulin resistance in diabetes mellitus. , 2004, European journal of pharmacology.

[25]  W. Duvall Endothelial dysfunction and antioxidants. , 2005, The Mount Sinai journal of medicine, New York.

[26]  I. West Radicals and oxidative stress in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[27]  Makoto Kanzaki,et al.  Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. , 2004, Endocrine reviews.

[28]  V. Skulachev Mitochondrial physiology and pathology; concepts of programmed death of organelles, cells and organisms. , 1999, Molecular aspects of medicine.

[29]  S. Kahn,et al.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.

[30]  U. Boggi,et al.  Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. , 2004, The Journal of clinical endocrinology and metabolism.

[31]  Jonathan S. Weissman,et al.  Oxidative protein folding in eukaryotes: mechanisms and consequences , 2004 .

[32]  M. Evans,et al.  Oxidative DNA damage and disease: induction, repair and significance. , 2004, Mutation research.

[33]  Abraham Nyska,et al.  Invited Review: Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their Quantification , 2002, Toxicologic pathology.

[34]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[35]  J. Weissman,et al.  Oxidative protein folding in eukaryotes , 2004, The Journal of cell biology.

[36]  É. Hajduch,et al.  Regulation of Glucose Transport and Glycogen Synthesis in L6 Muscle Cells during Oxidative Stress , 1999, The Journal of Biological Chemistry.

[37]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[38]  Graeme I. Bell,et al.  Diabetes mellitus and genetically programmed defects in β-cell function , 2001, Nature.

[39]  L. Philipson,et al.  Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic beta-cells? , 2004, Diabetes.

[40]  Ralph A. Evans,et al.  Editorial reasonable engineering guess , 2003, IEEE Trans. Reliab..

[41]  G I Bell,et al.  Diabetes mellitus and genetically programmed defects in beta-cell function. , 2001, Nature.

[42]  M. Roden,et al.  Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? , 2004, Diabetes.

[43]  I. G. Fantus,et al.  N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. , 2003, American journal of physiology. Endocrinology and metabolism.

[44]  R. Robertson Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes* , 2004, Journal of Biological Chemistry.

[45]  G. Rutter Nutrient-secretion coupling in the pancreatic islet beta-cell: recent advances. , 2001, Molecular aspects of medicine.

[46]  I. G. Fantus,et al.  Enhanced Sensitivity of Insulin-resistant Adipocytes to Vanadate Is Associated with Oxidative Stress and Decreased Reduction of Vanadate (+5) to Vanadyl (+4)* , 2001, The Journal of Biological Chemistry.

[47]  H. Kaneto,et al.  Role of oxidative stress in pancreatic beta-cell dysfunction. , 2004, Annals of the New York Academy of Sciences.

[48]  H. Kaneto,et al.  Role of Oxidative Stress in Pancreatic β‐Cell Dysfunction , 2004 .

[49]  J. McGarry Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.

[50]  H. Eldar-Finkelman,et al.  Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[51]  L. Philipson,et al.  Reactive species and early manifestation of insulin resistance in type 2 diabetes , 2006, Diabetes, obesity & metabolism.

[52]  A. Ergul,et al.  Oxidative stress and the use of antioxidants in diabetes : Linking basic science to clinical practice , 2015 .

[53]  G. Rutter Nutrient–secretion coupling in the pancreatic islet β-cell: recent advances , 2001 .

[54]  Toshiaki Tanaka,et al.  Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress. , 2004, Metabolism: clinical and experimental.

[55]  Lingyun Wu,et al.  Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. , 2003, American journal of hypertension.

[56]  J. Baynes,et al.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.

[57]  R. Henry Insulin resistance: from predisposing factor to therapeutic target in type 2 diabetes. , 2003, Clinical therapeutics.

[58]  H V Westerhoff,et al.  The Signal Transduction Function for Oxidative Phosphorylation Is at Least Second Order in ADP* , 1996, The Journal of Biological Chemistry.

[59]  J. Valentine,et al.  Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. , 2005, Annual review of biochemistry.

[60]  K. Petersen,et al.  Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. , 2002, The American journal of cardiology.

[61]  V. Skulachev Membrane-Linked Systems Preventing Superoxide Formation , 1997, Bioscience reports.

[62]  L. Orci,et al.  Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[64]  V. Skulachev,et al.  High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria , 1997, FEBS letters.